Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on September 14, 2026

35 minutes ago

Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)

Indeterminate GlobeNewswire

35 minutes ago

Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market

Indeterminate GlobeNewswire

35 minutes ago

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

35 minutes ago

VisionWave Files U.S. Non-Provisional Patent Application Describing ARGUS™, a Proposed Space-Enabled, AI-Driven Counter-Drone Defense Architecture

Indeterminate GlobeNewswire

35 minutes ago

Mavenir Celebrates Four Award-Winning Entries at Light Reading's 2026 Leading Lights Awards

Indeterminate GlobeNewswire

35 minutes ago

Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development

Indeterminate GlobeNewswire

35 minutes ago

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

Indeterminate GlobeNewswire

35 minutes ago

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

Indeterminate GlobeNewswire

35 minutes ago

Brazil Potash reduz capex inicial com contrato de energia de 28 anos para construção e backup

Indeterminate GlobeNewswire

35 minutes ago

Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract

Indeterminate GlobeNewswire

35 minutes ago

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

35 minutes ago

Kaplan Fox Alerts Investors of Microvast Holdings, Inc. (NASDAQ: MVST) with Significant Losses to a Securities Class Action Deadline on September 21, 2026

Indeterminate GlobeNewswire

35 minutes ago

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Indeterminate GlobeNewswire

35 minutes ago

Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors

Indeterminate GlobeNewswire

35 minutes ago

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Indeterminate GlobeNewswire

35 minutes ago

AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business

Indeterminate GlobeNewswire

35 minutes ago

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Indeterminate GlobeNewswire

35 minutes ago

Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days

Indeterminate GlobeNewswire

35 minutes ago

Four Cross-Generation LTO Tape Migration Myths, Starting With LTO-10

Indeterminate GlobeNewswire

35 minutes ago

Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project

Indeterminate GlobeNewswire